Soleno Therapeutics Inc. buy Guggenheim
Start price
27.08.25
/
50%
€59.30
Target price
27.08.26
€91.11
Performance (%)
-28.30%
Price
15.12.25
€43.40
Summary
This prediction is currently active. The price of Soleno Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.30%. This prediction currently runs until 27.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | 0.603% | 0.603% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Guggenheim for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $106.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Guggenheim for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€69.15
07.08.25
07.08.25
€90.90
07.08.26
07.08.26
-38.51%
15.12.25
15.12.25
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€67.90
08.05.25
08.05.25
€85.63
08.05.26
08.05.26
-37.38%
15.12.25
15.12.25
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€65.90
28.03.25
28.03.25
-
28.03.26
28.03.26
-35.48%
15.12.25
15.12.25
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.30
21.11.23
21.11.23
€36.55
21.11.24
21.11.24
106.38%
22.11.24
22.11.24